Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 2372 · DEVICE Act of 2025 ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

21 U.S.C. § 321 Definitions; generally

+6 −01 of 4 shown
More for 21 U.S.C. § 321
Read § 321Only this section
4 changes the bill asks for here, 1 carried out
  1. Not carried out:

    in clause (B), by striking or at the end;

    The bill points to paragraph (h) of § 321, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (h) in /us/usc/t21/s321
  2. Not carried out:

    in clause (C), by striking and at the end and inserting or; and

    The bill points to paragraph (h) of § 321, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (h) in /us/usc/t21/s321
  3. Not carried out:

    by inserting after clause (C) the following:(D) a rapid assessment test intended to ensure the proper reprocessing of a reusable device (as defined in paragraph (tt)), and; and

    The bill points to paragraph (h) of § 321, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (h) in /us/usc/t21/s321
  4. Carried out:

    by adding at the end the following:(tt) The term “reusable device” means a device that— (1) is intended to be used more than one time; and (2) must be sanitized (whether through cleaning, disinfection, or sterilization) to ensure that the device is safe and effective for such intended use..

§ 321(ss)–(tt)

Start of § 321 to (ss) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(ss)(1)(1) (1)
an infant formula; oran infant formula; or
(ss)(2)(2) (2)
a medical food, as defined in section 360ee(b)(3) of this title.a medical food, as defined in section 360ee(b)(3) of this title.
(tt)(tt) [inserted: ]
[inserted: The term “reusable device” means a device that—]
(tt)(1)(1) [inserted: ]
[inserted: is intended to be used more than one time; and]
(tt)(2)(2) [inserted: ]
[inserted: must be sanitized (whether through cleaning, disinfection, or sterilization) to ensure that the device is safe and effective for such intended use.]

21 U.S.C. § 360 Registration of producers of drugs or devices

+30 −0Shown
More for 21 U.S.C. § 360
Read § 360Only this section
3 changes the bill asks for here, 3 carried out
  1. Carried out:

    Section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360) is amended by adding at the end the following:(r) Reporting requirement for device design changes.— Before making a change to the design of a device, or the reprocessing instructions of a device, that is marketed in interstate commerce, the manufacturer of the device shall give written notice of the change to the Secretary..

  2. Carried out:

    Section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360), as amended by section 2 of this Act, is further amended by adding at the end the following:(s) Reporting requirement for certain communications to foreign health care providers.— (1) Requirement.— The manufacturer of a device that is marketed in interstate commerce shall give written notice to the Secretary of any communication described in paragraph (2) not more than …

  3. Carried out:

    Section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360), as amended by sections 2 and 3 of this Act, is further amended by adding at the end the following:(t) Instructions for use and validation data.— (1) Initial list.— Not later than 1 year after the date of enactment of this subsection, the Secretary shall by regulation develop and publish a list of types of rapid assessment tests described in section 201(h)(1)(D) for which …

§ 360(q)–(t)

Start of § 360 to (q)(1) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(q)(2)(2) Revision of list(2) Revision of list
The Secretary shall revise the list under paragraph (2),3 as the Secretary determines appropriate, with notice in the Federal Register.The Secretary shall revise the list under paragraph (2),3 as the Secretary determines appropriate, with notice in the Federal Register.
(q)(3)(3) Content of reports(3) Content of reports
Reports under subsection (k) that are submitted after the publication of the list described in paragraph (1), for devices or types of devices included on such list, shall include such instructions for use and validation data.Reports under subsection (k) that are submitted after the publication of the list described in paragraph (1), for devices or types of devices included on such list, shall include such instructions for use and validation data.
(r)(r) [inserted: Reporting requirement for device design changes.—]
[inserted: Before making a change to the design of a device, or the reprocessing instructions of a device, that is marketed in interstate commerce, the manufacturer of the device shall give written notice of the change to the Secretary.]
(s)(s) [inserted: Reporting requirement for certain communications to foreign health care providers.—]
(s)(1)(1) [inserted: Requirement.—]
[inserted: The manufacturer of a device that is marketed in interstate commerce shall give written notice to the Secretary of any communication described in paragraph (2) not more than 5 calendar days after making such communication.]
(s)(2)(2) [inserted: Communication described.—]
[inserted: A communication is described in this paragraph if the communication—]
(s)(2)(A)(A) [inserted: ]
[inserted: is made by the manufacturer of the device or an affiliate of the manufacturer;]
(s)(2)(B)(B) [inserted: ]
[inserted: relates to a change to the design of the device, a change to the recommended reprocessing protocols, if any, for the device, or a safety concern about the device; and]
(s)(2)(C)(C) [inserted: ]
[inserted: is widely disseminated (including on a voluntary basis) to health care providers in a foreign country.]
(s)(3)(3) [inserted: Affiliate.—]
[inserted: In this subsection, the term “affiliate” means a business entity that has a relationship with a second business entity if, directly or indirectly—]
(s)(3)(A)(A) [inserted: ]
[inserted: one business entity controls, or has the power to control, the other business entity; or]
(s)(3)(B)(B) [inserted: ]
[inserted: a third party controls, or has the power to control, both of the business entities.]
(t)(t) [inserted: Instructions for use and validation data.—]
(t)(1)(1) [inserted: Initial list.—]
[inserted: Not later than 1 year after the date of enactment of this subsection, the Secretary shall by regulation develop and publish a list of types of rapid assessment tests described in section 201(h)(1)(D) for which reports under subsection (k) must include—]
(t)(1)(A)(A) [inserted: ]
[inserted: instructions for use that have been validated in a manner specified by the Secretary; and]
(t)(1)(B)(B) [inserted: ]
[inserted: validation data, of the types specified by the Secretary.]
(t)(2)(2) [inserted: Updates.—]
[inserted: The Secretary shall by regulation periodically update the list required by paragraph (1).]
(t)(3)(3) [inserted: Enforcement.—]
[inserted: Beginning on the date of publication of the initial list under paragraph (1), the Secretary shall not accept any notification under subsection (k) for clearance of a type of rapid assessment test that is included on such list unless such notification includes instructions for use and validation data in accordance with paragraph (1).]

21 U.S.C. § 351 Adulterated drugs and devices

Couldn't place 2 changes
More for 21 U.S.C. § 351
Read § 351Only this section

The bill's words for this section

  1. Not carried out:

    Section 501 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 351) is amended by inserting after paragraph (j) the following:(k) If it is a device with respect to which the manufacturer is in violation of the reporting requirement under section 510(r) (relating to design and reprocessing changes)..

    The bill points to paragraph (j) of § 351, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailno paragraph (j) in /us/usc/t21/s351
  2. Not carried out:

    Section 501 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 351), as amended by section 2 of this Act, is further amended by inserting after paragraph (k) the following:(l) If it is a device with respect to which the manufacturer is in violation of the reporting requirement under section 510(s) (relating to communications to foreign health care providers)..

    The bill points to paragraph (k) of § 351, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailno paragraph (k) in /us/usc/t21/s351

Step through the changes